Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FLT3 D835Y
i
Other names:
FLT3, Fms Related Tyrosine Kinase 3, Receptor-Type Tyrosine-Protein Kinase FLT3, Stem Cell Tyrosine Kinase 1, Fms-Like Tyrosine Kinase 3, CD135, FLK-2, STK1, Growth Factor Receptor Tyrosine Kinase Type III, Fetal Liver Kinase 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2322
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
FLT3 amplification (1)
FLT3 amplification (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
midostaurin
Sensitive: C2 – Inclusion Criteria
midostaurin
Sensitive
:
C2
midostaurin
Sensitive: C2 – Inclusion Criteria
midostaurin
Sensitive
:
C2
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
quizartinib
Resistant: C3 – Early Trials
quizartinib
Resistant
:
C3
quizartinib
Resistant: C3 – Early Trials
quizartinib
Resistant
:
C3
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
sunitinib
Resistant: C3 – Early Trials
sunitinib
Resistant
:
C3
sunitinib
Resistant: C3 – Early Trials
sunitinib
Resistant
:
C3
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
sorafenib
Resistant: C3 – Early Trials
sorafenib
Resistant
:
C3
sorafenib
Resistant: C3 – Early Trials
sorafenib
Resistant
:
C3
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
imatinib
Sensitive: C4 – Case Studies
imatinib
Sensitive
:
C4
imatinib
Sensitive: C4 – Case Studies
imatinib
Sensitive
:
C4
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
pexidartinib
Sensitive: C4 – Case Studies
pexidartinib
Sensitive
:
C4
pexidartinib
Sensitive: C4 – Case Studies
pexidartinib
Sensitive
:
C4
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
Max-40279
Sensitive: D – Preclinical
Max-40279
Sensitive
:
D
Max-40279
Sensitive: D – Preclinical
Max-40279
Sensitive
:
D
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
ponatinib
Resistant: D – Preclinical
ponatinib
Resistant
:
D
ponatinib
Resistant: D – Preclinical
ponatinib
Resistant
:
D
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
gilteritinib
Sensitive: D – Preclinical
gilteritinib
Sensitive
:
D
gilteritinib
Sensitive: D – Preclinical
gilteritinib
Sensitive
:
D
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
MLN518
Resistant: D – Preclinical
MLN518
Resistant
:
D
MLN518
Resistant: D – Preclinical
MLN518
Resistant
:
D
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
SU5614
Sensitive: D – Preclinical
SU5614
Sensitive
:
D
SU5614
Sensitive: D – Preclinical
SU5614
Sensitive
:
D
FLT3 D835Y
Acute Myelogenous Leukemia
FLT3 D835Y
Acute Myelogenous Leukemia
BGS-2456
Sensitive: D – Preclinical
BGS-2456
Sensitive
:
D
BGS-2456
Sensitive: D – Preclinical
BGS-2456
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.